AVITA Medical (RCEL) Research & Development (2018 - 2025)
Historic Research & Development for AVITA Medical (RCEL) over the last 8 years, with Q4 2025 value amounting to -$36.0 million.
- AVITA Medical's Research & Development fell 32.62% to -$36.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$20.8 million, marking a year-over-year decrease of 234.27%. This contributed to the annual value of -$20.8 million for FY2025, which is 235.27% down from last year.
- Latest data reveals that AVITA Medical reported Research & Development of -$36.0 million as of Q4 2025, which was down 32.62% from $3.7 million recorded in Q3 2025.
- AVITA Medical's Research & Development's 5-year high stood at $6.8 million during Q4 2023, with a 5-year trough of -$36.0 million in Q4 2025.
- Moreover, its 5-year median value for Research & Development was $4.1 million (2021), whereas its average is $260526.3.
- As far as peak fluctuations go, AVITA Medical's Research & Development soared by 10020.72% in 2023, and later tumbled by 63022.91% in 2024.
- Over the past 5 years, AVITA Medical's Research & Development (Quarter) stood at $3.4 million in 2021, then dropped by 0.27% to $3.4 million in 2022, then skyrocketed by 100.21% to $6.8 million in 2023, then tumbled by 630.23% to -$35.9 million in 2024, then decreased by 0.33% to -$36.0 million in 2025.
- Its last three reported values are -$36.0 million in Q4 2025, $3.7 million for Q3 2025, and $5.1 million during Q2 2025.